In an analysis of yeast mutants resistant to trifluoroleucine, approximately half of the mutants were found to have a reduced sensitivity of a-isopropylmalate synthetase to leucine inhibition. This end-product-insensitive mutation was found to be dominant in diploids. Most other anticipated mechanisms underlying amino acid analogue resistance would be expected to be recessive characters. Examples would include altered permeases, aminoacyl-transfer ribonucleic acid (RNA) synthetases, transfer RNA species, and regulatory sites controlling synthesis of the biosynthetic enzymes by all but positive control elements. Such a positive control could alter production of some component necessary for synthesis of the controlled genes, as postulated for the L-arabinose operon (1) . Derepression of amino acid biosynthetic enzymes does not seem to occur to an appreciable extent in yeast, and may not be a common mechanism for analogue resistance in this organism.
Canavanine-resistant mutants with an altered arginine permease have been shown to be recessive (6) , and use has been made of this property to select for haploids against diploids (4). Ethionine-resistance mutations in two loci have been found, one for general uptake of amino acids, aap (5), and one for methionine uptake, met-p (2); both are recessive. An initial screen involving a genetic test for dominance has been employed to distinguish recessive analogue-resistant mutants from those in which resistance is due to end-product-insensitive mutations. The method may be of general application.
Another possible type of dominant analogueresistant mutant could have an altered positive control element as discussed above. Mutants with altered regulation of a leucine biosynthetic enzyme and leucine uptake have been isolated (manuscript in preparation) and may be of this type. This latter class contains approximately 10% of total mutants, and the dominance test will clearly not distinguish them from the endproduct-insensitive class; rather, some direct enzymatic screen would be required.
By using Saccharomyces cerevisiae strain SCF39 a his-, obtained from G. R. Fink, a series of spontaneous mutants resistant to 5'-5'-5'-trifluoro-D-L-leucine were isolated. Strain RS27/ J-R his4 (a bradyotrophic leucine prototroph derived by reversion from RS27/1 a leu2 his4) was used to make mutants resistant to 4-azaleucine which were also found to be trifluoroleucineresistant.
Mutants from both sources were mated with strain A941B a trp-by using the method described by Fink (in press; Methods in enzymology, 1969). Diploids from this cross were selected by plating on minimal medium, and analogue resistance was tested for by replica plating on minimal medium containing 1 X 10-3 M trifluoroleucine.
Haploid, analogue-resistant mutants were grown on minimal medium, and the specific activity of the a-isopropylmalate synthetase and its sensitivity to leucine inhibition were measured as described previously (3). The results (see Table 1 ) show that of the 10 dominant mutants examined, none were markedly derepressed for a-isopropylmalate synthetase, though in SCF3909 the specific activity was twofold higher. In all cases, however, the enzyme had a reduced sensitivity to leucine inhibition. Leucine at 0.01 M in the assay completely inhibited the activity of the wild-type enzyme, whereas, in the dominant mutants, inhibition varied from 0 to 56%. The one recessive mutant tested, SCF3904, had an a-isopropylmalate synthetase with essentially normal sensitivity to leucine.
Presumably, sufficient leucine-insensitive a-isopropylmalate synthetase would be present in the dominant diploids to over-produce leucine to compete with the analogue. 
